Clinical Trial

A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated November 6, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of the study is to determine the effect of MAR001 as compared to placebo on levels of the triglycerides (TG) in the postprandial state in adults with elevated TG.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-22.
Trial Details
NCT Number NCT07199309
Lead Sponsor Marea Therapeutics
Conditions Hypertriglyceridemia
Enrollment 30 participants
Start Date 2025-09-26
Primary Completion 2026-07 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-11-06